Search clinical trials for: T89
Total 135 results
-
Tasly Pharmaceuticals, Inc.Completed
-
Tasly Pharmaceuticals, Inc.ParexelCompletedHealthyUnited States
-
Tasly Pharmaceuticals, Inc.WithdrawnCoronavirus Disease 2019 | Novel Coronavirus Pneumonia
-
Tasly Pharmaceuticals, Inc.RecruitingChronic Stable Angina PectorisUnited States
-
Tasly Pharmaceuticals, Inc.CompletedAngina PectorisCanada, United States, Russian Federation, Belarus, Georgia, Mexico, Ukraine
-
Tasly Pharmaceuticals, Inc.Tasly Pharmaceutical Group Co., LtdNo longer available
-
Tasly Pharmaceuticals, Inc.RecruitingAcute Mountain Sickness (AMS)United States, China
-
Tasly Pharmaceuticals, Inc.CompletedAcute Mountain Sickness (AMS)United States
-
Neuralstem Inc.UnknownMajor Depressive DisorderUnited States
-
Hutchison Medipharma LimitedCompleted
-
Tasly Pharmaceuticals, Inc.CompletedAngina PectorisUnited States
-
Neuralstem Inc.Unknown
-
HutchmedActive, not recruitingLymphomaSpain, United States, France, Italy, Finland, Poland
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
AbbottTerminatedAlzheimer's DiseaseUnited States
-
AbbottTerminatedA Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseAlzheimer's DiseaseUnited States
-
Jeil Pharmaceutical Co., Ltd.UnknownClinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic StrokeAcute Ischemic StrokeKorea, Republic of
-
Hutchison Medipharma LimitedCompleted
-
AbbottTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer Disease | Healthy SubjectsUnited States
-
Boston PharmaceuticalsCompletedDiarrhea-predominant Irritable Bowel SyndromeUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
HutchmedRecruitingRelapsed/Refractory LymphomaChina
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawn
-
Jeil Pharmaceutical Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
BiocadCompletedSeropositive RARussian Federation, Belarus
-
Jeil Pharmaceutical Co., Ltd.Completed
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Neuralstem Inc.CompletedDepressionUnited States
-
National Center of Neurology and Psychiatry, JapanNippon Shinyaku Co., Ltd.Completed
-
Nippon Shinyaku Co., Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnSchizophreniaUnited States, France
-
Edison Pharmaceuticals IncCompletedParkinson's DiseaseUnited States, Germany, United Kingdom
-
PTC TherapeuticsCompletedAmyotrophic Lateral SclerosisUnited States
-
Achaogen, Inc.Completed
-
Beijing InnoCare Pharma Tech Co., Ltd.Not yet recruitingPatients With Advanced Solid TumorsChina
-
Neuralstem Inc.Completed
-
ValentisCompletedIntermittent Claudication | Peripheral Vascular DiseaseUnited States
-
Boehringer IngelheimCompleted
-
Hutchison Medipharma LimitedRecruitingFollicular Lymphoma | Marginal Zone LymphomaChina
-
AbbottTerminatedAlzheimer's DiseaseUnited States
-
Peking Union Medical College HospitalNot yet recruitingBone Metastases | Thyroid Neoplasm FollicularChina
-
Akili Interactive Labs, Inc.CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of PennsylvaniaTerminated